Cargando…

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.

Detalles Bibliográficos
Autores principales:	Workman, P., Bleehen, N. M., Wiltshire, C. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1980
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010192/ https://www.ncbi.nlm.nih.gov/pubmed/7370170

Ejemplares similares

Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.
por: Workman, P., et al.
Publicado: (1978)

Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
por: Workman, P.
Publicado: (1979)

Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
por: Astor, M., et al.
Publicado: (1979)

Modulation of the hypoxic toxicity and binding of misonidazole by glucose.
por: Ling, L. L., et al.
Publicado: (1986)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
por: Moore, J. L., et al.
Publicado: (1981)

A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
por: Abratt, R. P.
Publicado: (1982)

The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.
por: Sheldon, P. W., et al.
Publicado: (1984)

Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
por: Honess, D. J., et al.
Publicado: (1980)

An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
por: Twentyman, P. R., et al.
Publicado: (1983)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
por: Overgaard, J., et al.
Publicado: (1982)

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
por: Rojas, A., et al.
Publicado: (1983)

Interactions between misonidazole and hyperthermia in EMT6 spheroids.
por: Morgan, J. E., et al.
Publicado: (1981)

Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
por: Lee, F. Y., et al.
Publicado: (1985)

Dependence of misonidazole binding on factors associated with hypoxic metabolism.
por: Ling, L. L., et al.
Publicado: (1987)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
por: Bleehen, N. M., et al.
Publicado: (1981)

The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice.
por: Walton, M. I., et al.
Publicado: (1987)

Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.
por: Stratford, I. J., et al.
Publicado: (1980)

Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
por: Franko, A. J., et al.
Publicado: (1982)

Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
por: Pedersen, J. E., et al.
Publicado: (1979)

Reactions in the Radiosensitizer Misonidazole Induced by Low-Energy (0–10 eV) Electrons
por: Meißner, Rebecca, et al.
Publicado: (2019)

Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
por: Brown, J. M., et al.
Publicado: (1979)

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
por: Hirst, D. G., et al.
Publicado: (1982)

Effect of local hyperthermia on the acute toxicity of misonidazole in mice.
por: Overgaard, J.
Publicado: (1979)

Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
por: Lee, F. Y., et al.
Publicado: (1983)

Psychosis as Harbinger of Phenytoin Toxicity
por: Borasi, Manish, et al.
Publicado: (2015)

Radiosensitizers of Hypoxic Cells
por: Nias, A. H. W.
Publicado: (1980)

Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
por: Taylor, Y. C., et al.
Publicado: (1980)

Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
por: Lee, F. Y., et al.
Publicado: (1984)

Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-9963) in dogs
por: White, R. A. S., et al.
Publicado: (1980)

Phenytoin Toxicity from Cocaine Adulteration
por: Roldan, Carlos J.
Publicado: (2014)

Phenytoin-Induced Toxic Epidermal Necrolysis
por: Tunuguntla, Mounika Nagarani, et al.
Publicado: (2023)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Shortening the Half-Life of Cas9 Maintains Its Gene Editing Ability and Reduces Neuronal Toxicity
por: Yang, Su, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_os2fq1ssn2i0nnrm8alk95ils6